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Microorganisms in the gastrointestinal tract interact with their host in many ways 
and contribute significantly to the maintenance of host health (1).  Lipid metabolism by 
gastrointestinal microbes generates multiple fatty-acid species, such as conjugated fatty acids 
and trans-fatty acids, that can affect host lipid metabolism (2).  In the representative gut 
bacterium Lactobacillus plantarum, we identified genes encoding the enzymes involved in a 
novel saturation metabolism of polyunsaturated fatty acids, and revealed in detail the 
metabolic pathway that generates hydroxy fatty acids, oxo fatty acids, conjugated fatty acids, 
and partially saturated trans-fatty acids as intermediates.  Furthermore, we observed these 
intermediates, especially hydroxy fatty acids, in host organs.  Levels of hydroxy fatty acids 
were much higher in specific pathogen–free mice than in germ-free mice, indicating that 
these fatty acids are generated through polyunsaturated fatty acids metabolism of 
gastrointestinal microorganisms.  These findings suggested that lipid metabolism by 
gastrointestinal microbes affect the health of the host by modifying fatty-acid composition.  
 
1. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses 
during health and disease. Nat. Rev. Immunol. 9(5): 313-323. 
2. Griinari JM, Bauman DE (1999) in Advances in conjugated linoleic acid research., eds 






Dietary fats are metabolized not only by humans, but also by microbes in our 
gastrointestinal tracts.  However, lipid metabolism by gastrointestinal microbes has not been 
explored in detail.  Saturation metabolism of polyunsaturated fatty acids, a representative 
mode of lipid metabolism by gastrointestinal microbes, is a detoxifying metabolism of 
anaerobic bacteria, such as lactic-acid bacteria, that reside in colon and intestine.  This 
process transforms growth-inhibiting free polyunsaturated fatty acids into less toxic free 
saturated fatty acids (3).  This saturation metabolism generates characteristic fatty acids, e.g., 
conjugated fatty acids and trans-fatty acids, which are well known to present in ruminant-
derived foods and exert various physiological activities.   
‘Conjugated fatty acid’ is a collective term for positional and geometric isomers of 
fatty acids with conjugated double bonds.  In particular, conjugated linoleic acids (CLAs) 
such as cis-9,trans-11-CLA and trans-10,cis-12-CLA reduce carcinogenesis (4), 
atherosclerosis (5), and body fat (6).  In regard to lipid metabolism, CLA is a potent 
peroxisome proliferator-activated receptor α (PPARα) agonist (7), and treatment with CLA 
increases the catabolism of lipids in the liver of rodents (8).  Based on these findings, CLA is 
now commercialized as a functional food for control of body weight, especially in the USA 
and European countries.  
On the other hand, consumption of trans-fatty acids increases the risk of coronary 
heart disease by increasing LDL and reducing HDL cholesterol levels (9).  Consequently, 
trans-fatty acids are considered to be harmful for health, and nutritional authorities have 
recommended that consumption of trans-fatty acids be reduced to trace amounts (10).  
Therefore, it is important to control fatty acid saturation processes that generate these fatty 
acids (11); however, the precise metabolic pathway and enzymes involved have not been 
clearly identified. 
Our analyses on conjugated fatty acid synthesis in representative gut bacteria, the 
lactic-acid bacteria (12-15), demonstrated that Lactobacillus plantarum AKU 1009a can 
transform the cis-9,cis-12 diene structure of C18 fatty acids such as linoleic acid, α-linolenic 
acid, and γ-linolenic acid into the conjugated diene structures cis-9,trans-11 and trans-
9,trans-11 (16-21).  In addition, this strain can saturate these conjugated dienes into the trans-
10 monoene.  Our subsequent metabolic analysis indicated that 10-hydroxy-12-octadecenoic 
acid is an intermediate of CLA synthesis, and further investigations of hydroxy fatty-acid 
metabolism by lactic-acid bacteria revealed that CLA is produced from hydroxy fatty acids 
such as ricinoleic acid in castor oil (22-25).   In cell-free extracts from this strain, we 
identified the enzymes involved in CLA synthesis (26).  Three enzymes, CLA-HY, CLA-DH, 
and CLA-DC, are necessary for synthesis of conjugated fatty acids such as CLA.  Only the 
combined action of these three enzymes can generate CLA from linoleic acid, with 10-
hydroxy-cis-12-octadecenoic acid arising as an intermediate (Figure 1B-3).  The reactions 
catalyzed by each enzyme, however, were not revealed in those studies.  Through genomic 
analysis in L. plantarum WCFS1, we found that cla-dh (GeneID: 1061221) and cla-dc 
(GeneID: 1061220) are located in a cluster with another gene, cla-er (GeneID: 1061219) 
(Figure 1A).  In light of this, we tried to identify the function of the gene product (CLA-ER) 




Results and Discussion 
Based on the sequence of the L. plantarum WCFS1 genome, we designed primers 
to amplify the CLA-ER gene from L. plantarum AKU 1009a genomic DNA.  The PCR-
amplified product, cla-er (GenBank ID: AB812091), consisted of 654 bp and encoded a 
protein whose amino-acid sequence is 99.8% identical to the homologous sequence from L. 
plantarum WCFS1.  We transformed the resulting plasmid containing cla-er from L. 
plantarum AKU 1009a, pCLA-ER, into E. coli RosettaTM2 (DE3) to generate E. coli 
Rosetta/pCLA-ER.  The gene product, CLA-ER, had a molecular weight of ~25 kDa 
(including a His tag), and could be detected in soluble cell-free extracts of E. coli 
Rosetta/pCLA-ER.  We examined the function of CLA-ER in fatty-acid metabolism using 
purified CLA-ER in combination with other purified enzymes (CLA-HY, CLA-DH, and 
CLA-DC) from the corresponding transformants (E. coli Rosetta/pCLA-HY, E. coli 
Rosetta/pCLA-DH, and E. coli Rosetta/pCLA-DC). 
In a reaction with these four enzymes (CLA-HY, CLA-DH, CLA-DC, and CLA-
ER) as catalysts, cis-9,trans-11-CLA (CLA1), trans-9,trans-11-CLA (CLA2), 10-hydroxy-
cis-12-octadecenoic acid, trans-10-octadecenoic acid, and cis-9-octadecenoic acid (oleic 
acid) were generated from linoleic acid (Figure 1B-4).  Thus, the combined action of these 
four enzymes generated saturated products of oleic acid and trans-10-octadecenoic acid from 
linoleic acid, i.e., these four enzymes catalyzed the saturation of an polyunsaturated fatty acid. 
In our previous studies, we revealed that linoleic acid could be converted into 10-
hydroxy-cis-12-octadecenoic acid by CLA-HY (Figure 1B-2), as well as into CLA1 and 
CLA2 along with 10-hydroxy-cis-12-octadecenoic acid by CLA-HY, CLA-DH, and CLA-
DC (Figure 1B-3).  We purified the resulting 10-hydroxy-cis-12-octadecenoic acid by high-
performance liquid chromatography (HPLC) and used it as a substrate for reactions 
containing each enzyme together with the oxidoreduction cofactors, i.e., FAD, NADH, or 
NADPH, that enhanced CLA synthesis by CLA-HY, CLA-DH, and CLA-DC (14).  10-
Hydroxy-cis-12-octadecenoic acid was converted into linoleic acid and trans-10,cis-12-
octadecadienoic acid by CLA-HY in the presence of FAD and NADH (Figure S1).  The same 
substrate was converted into 10-oxo-cis-12-octadecenoic acid by CLA-DH in the presence of 
NAD+ (Figure S2).  As before, we purified the resulting trans-10,cis-12-octadecadienoic acid 
and 10-oxo-cis-12-octadecenoic acid by HPLC and used them as substrates in subsequent 
reactions. 
None of the enzymes converted trans-10,cis-12-octadecadienoic acid under any 
conditions tested.  By contrast, 10-oxo-cis-12-octadecenoic acid was converted into 10-oxo-
trans-11-octadecenoic acid by CLA-DC in the absence of cofactors (Figure S3).  HPLC-
purified 10-oxo-trans-11-octadecenoic acid was converted into 10-oxo-octadecanoic acid by 
CLA-ER in the presence of FAD/FMN and NADH (Figure S4), and was converted into 10-
hydroxy-trans-11-octadecenoic acid by CLA-DH in the presence of NADH (Figure S5).  
Purified 10-oxo-octadecanoic acid was converted into 10-hydroxy-octadecanoic acid by 
CLA-DH in the presence of NADH (Figure S6), and this product was in turn converted into 
cis-9-octadecenoic acid and trans-10-octadecenoic acid by CLA-HY in the presence of FAD 
and NADH (Figure S7).  The 10-hydroxy-trans-11-octadecenoic acid could also be converted 
into cis-9,trans-11-CLA and trans-9,trans-11-CLA by CLA-HY in the presence of FAD and 
NADH (Figure S8). 
These results demonstrate that the linoleic-acid saturation metabolism of 
Lactobacillus plantarum consists of multiple reactions.  The first reaction of linoleic-acid 
metabolism is hydration of the carbon-carbon double bond at the delta-9 position, catalyzed 
by CLA-HY, to generate 10-hydroxy fatty acid.  The second reaction is dehydrogenation of 
the hydroxy group at C10, catalyzed by CLA-DH, to generate 10-oxo fatty acid.  The third 
reaction is isomerization of the carbon-carbon double bond at delta-12, catalyzed by CLA-
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DC, to generate the conjugated enone structure, 10-oxo-trans-11-fatty acid.  The fourth 
reaction is hydrogenation of the carbon-carbon double bond at delta-11, catalyzed by CLA-
ER, to generate the carbon-carbon single bond.  The fifth reaction is hydrogenation of the oxo 
group at C10, catalyzed by CLA-DH, to generate 10-hydroxy fatty acid.  The last reaction is 
dehydration of hydroxy group at C10, catalyzed by CLA-HY, to generate cis-9 and trans-10 
monoenoic fatty acids.  Through a branch of the saturation-metabolism pathway, conjugated 
fatty acids are generated by the combined actions of three of the enzymes, CLA-HY, CLA-
DH, and CLA-DC.  The branched pathway starts with hydrogenation of the oxo group at C10 
in 10-oxo-trans-11-fatty acid, catalyzed by CLA-DH, to generate 10-hydroxy-trans-11-fatty 
acid; the final reaction is dehydration of hydroxy group at C10 in 10-hydroxy-trans-11-fatty 
acid, catalyzed by CLA-HY, to generate cis-9,trans-11 and trans-9,trans-11 conjugated fatty 
acids (Figure 2).  As we reported previously, C18 fatty acids with Δ9 and Δ12 diene systems 
such as α-linolenic acid, γ-linolenic acid, and stearidonic acid undergo the same 
transformations in L. plantarum AKU 1009a (20), indicating that the corresponding 
intermediates (hydroxy, oxo, conjugated, and partially saturated trans-fatty acids) are 
produced by the combined actions of these enzymes.  The revealed fatty acid saturation 
metabolism consists of similar reactions in known fatty acid biosynthesis and degradation 
pathway, however, it is completely new pathway using only free fatty acids as substrates but 
not CoA- or acyl carrier protein-activated fatty acids.   
In the experiments described above, we revealed the pathway of unsaturated fatty-
acid metabolism in L. plantarum and the enzymes involved in this metabolism.  These 
enzymes function as catalysts of hydration/dehydration (CLA-HY), oxidation of hydroxy 
groups/reduction of oxo groups (CLA-DH), migration of carbon-carbon double bonds (CLA-
DC), and saturation of carbon-carbon double bonds (CLA-ER).  The genes that encode CLA-
DH, CLA-DC, and CLA-ER form a gene cluster in L. plantarum.  When we searched for 
gene clusters containing cla-dh, cla-dc, and cla-er in other microorganisms using the KEGG 
database (Kyoto Encyclopedia of Genes and Genomes, http://www.genome.jp/kegg/), we 
found that Lactobacillus casei and Lactobacillus rhamnosus have the same gene cluster as 
well as the cla-hy gene.  Furthermore, many species of lactic-acid bacteria have one or more 
of these four genes.  For example, Lactobacillus salivarius has cla-dc, cla-er, and cla-hy; and 
Lactobacillus amylovorus, Lactobacillus johnsonii, Lactobacillus helveticus, and 
Lactobacillus crispatus have cla-dh, cla-er, and cla-hy.  Therefore, acting in concert, these 
species may mediate the polyunsaturated fatty acid saturation metabolism in gastrointestinal 
tract.  The in vivo distributions of these strains in relation with the fatty acid profiles and the 
health conditions of host organisms are further interests.   
The reactions and enzymes we identified will be useful for modifying the properties 
of fatty acids in foods.  The apparent isomerization reaction catalyzed by the combined 
activities of CLA-HY, CLA-DH, and CLA-DC will be useful for production of cis-9,trans-
11- and trans-9,trans-11-conjugated fatty acids.  The other isomerization reaction catalyzed 
by CLA-HY will be useful for production of trans-10,cis-12-conjugated fatty acids.  
Furthermore, the dehydration reaction catalyzed by CLA-HY might determine the ratio of 
trans to cis-fatty acids.  In other words, enhancing cis-dehydration by CLA-HY could be 
useful for reducing the amounts of trans-fatty acid in foods.  This might be possible as we 
reported previously that the CLA1/CLA2 ratio (cis/trans ratio) can be controlled by 
optimizing the reaction conditions (14, 16).  Furthermore, not only in food industry, but also 
in chemical industry, the reactions found in the fatty acid saturation metabolism are useful, 
e.g. enzymatic production of hydroxy fatty acids for polymer industry.   
To evaluate the effects of gastrointestinal bacteria on the profile of fatty acids in 
host tissues, we monitored endogenous formation of the fatty-acid intermediates of 
polyunsaturated fatty acid saturation metabolism, i.e., hydroxy and oxo fatty acids, in mice 
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bred in either germ-free or specific pathogen–free (SPF) conditions.  In the colon, small 
intestine, and plasma of both groups of mice, we detected 10-hydroxy-cis-12-octadecenoic 
acid, 10-hydroxyoctadecanoic acid, and 10-oxooctadecanoic acid.  By contrast, we did not 
detect 10-oxo-cis-12-octadecenoic acid or 10-oxo-trans-11-octadecenoic acid derived from 
linoleic acid, or metabolites derived from α-linolenic acid and γ-linolenic acid.  There were 
significant differences in the levels of hydroxy fatty acids between SPF and germ-free mice: 
in particular, we observed higher levels of 10-hydroxy fatty acids derived from linoleic acid, 
oleic acid, or both in SPF mice than in germ-free mice (Figure 3).  We also detected a 
structurally related hydroxy fatty acid, 13-hydroxy-9-cis-octadecenoic acid, which is 
produced by lactic-acid bacteria (27), at higher levels in SPF mice than in germ-free mice 
(Figure 3).  These differences in the levels of hydroxy fatty acids could be clearly observed in 
the small intestine, the primary site of fatty acid absorption.  These results indicate that 
gastrointestinal microbes play roles in modifying the fatty-acid profiles of their host mice, in 
particular by increasing the levels of hydroxy fatty acids that are initial intermediates of 
polyunsaturated fatty acid saturation metabolism. The investigations using mono-colonize 
germ-free mice with L. plantarum or a strain deficient in one or more of the fatty acid 
saturating genes to see whether the host accumulates intermediates are also future interests.   
The intermediates found in the novel polyunsaturated fatty acid saturation 
metabolism are predicted to exert specific physiological functions.  For example, hydroxy 
and oxo fatty acids act as ligands for PPARγ (28); oxo-fatty acids found in tomato juice are 
potent PPARα activators and decrease the amount of triacylglycerol in obese diabetic mice 
(29).  Therefore, functional investigations of these fatty-acid intermediates of the 
polyunsaturated fatty acid saturation metabolism will provide new methods for improving our 
health by altering lipid metabolism related to the onset of metabolic syndrome.  Exploration 
of the lipid metabolism of gastrointestinal microorganisms at the enzymatic and genetic 
levels, and integration of these findings with metagenomic information, might enable us to 
promote health by controlling intestinal lipid metabolism. 
 
Materials and Methods 
Chemicals 
Standard samples of cis-9,trans-11-CLA, trans-9,trans-11-CLA, and 10-hydroxy-cis-
12-octadecenoic acid were prepared as previously described (11, 13).  Linoleic acid and fatty 
acid–free (<0.02%) bovine serum albumin (BSA) were purchased from Sigma (St. Louis, 
MO, USA).  All other chemicals were analytical grade and obtained commercially. 
 
Cloning and expression of recombinant CLA-ER proteins in E. coli 
Primers were designed to amplify the cla-er sequence from L. plantarum AKU 1009a 
genomic DNA.  The PCR-amplified product was ligated into the pET101/D-TOPO 
expression vector (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s 
instructions.  The resulting plasmid, pCLA-ER, was transformed into E. coli RosettaTM2 
(DE3) (Novagen, Madison, WI, USA) to generate E. coli Rosetta/pCLA-ER.  The integrity of 
the cloned gene was verified by DNA sequencing using a Beckman-Coulter CEQ8000 
(Beckman Coulter, Fullerton, CA, USA).   
 
Expression of recombinant proteins in E. coli 
Transformants (E. coli Rosetta/pCLA-HY, E. coli Rosetta/pCLA-DH, E. coli 
Rosetta/pCLA-DC, and E. coli Rosetta/pCLA-ER) were cultured in Luria-Bertani (LB) 
medium at 37°C for 1 h with shaking at 300 rpm, and then isopropyl-β-thiogalactopyranoside 
(IPTG) was added to a final concentration of 1.0 mM.  After addition of IPTG, the 
transformed cells were cultivated at 20°C for 6 h with shaking at 300 rpm.  The cells were 
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harvested by centrifugation (12,000 × g, 10 min), washed twice with 0.85% NaCl, and stored 
at −20°C until further use. 
 
Purification of enzymes from transformants 
To determine the approximate concentration of protein eluted in chromatography, 
effluents were monitored by UV detection at 280 nm.  Enzymes were purified using a fast 
protein liquid chromatography (FPLC) system (Amersham Pharmacia Biotech Co., Uppsala, 
Sweden) equilibrated with binding buffer (20 mM potassium phosphate buffer (KPB), 50 
mM imidazole, pH 7.4) or standard buffer (20 mM KPB, 1 mM DTT, 10% ethylene glycol, 
pH 6.5).  Fractions with enzymatic activity were collected and concentrated using an Amicon 
Ultra YM-10 (Millipore, Billerica, MA, USA).  All procedures were carried out at 4°C. 
 CLA-HY and CLA-ER were purified as His-tagged proteins.  E. coli 
Rosetta/pCLA-HY and E. coli Rosetta/pCLA-ER cells (8 g) in 1.5 L of culture broth were 
suspended in binding buffer and disrupted with an Insonator 201M ultrasonic oscillator 
(Kubota, Osaka, Japan).  After ultracentrifugation (100,000 × g, 60 min) of the cell lysate, the 
resulting supernatant containing His-tagged CLA-HY or His-tagged CLA-ER was loaded 
onto a Ni-Sepharose column (His Trap HP; GE Healthcare, Buckinghamshire, UK) pre-
equilibrated with binding buffer.  After washing, the bound proteins were eluted with elution 
buffer (20 mM KPB, 250 mM imidazole, pH 7.4).  Active fractions were collected and 
concentrated with a Centriprep YM-3 (Millipore) and applied to a Hi-load 26/60 Superdex 
200 prep-grade column (GE Healthcare) equilibrated with 50 mM KPB (pH 6.5).  Active 
fractions were collected, dialyzed with 50 mM KPB (pH 6.5) including 50% (v/v) glycerol, 
and stored at −20°C until use. 
 For purification of CLA-DH, E. coli Rosetta/pCLA-DH cells (8 g) in 1.5 L of 
culture broth were suspended in BugBuster Master Mix (Merck, Darmstadt, Germany) (30 
ml) and incubated for 20 min at room temperature.  After ultracentrifugation (100,000 × g, 60 
min) of the cell lysate, the resulting supernatant was concentrated with a Centriprep YM-3 
and applied to a HiLoad 26/60 Superdex 200 prep-grade column that had been equilibrated 
with standard buffer and eluted. CLA-DH was purified further using a Mono Q 10/100 GL 
column and a Superdex 200 10/300 GL column (GE Healthcare).  The purified CLA-DH was 
dialyzed with 50 mM KPB (pH 6.5) including 50% (v/v) glycerol and stored at −20°C until 
use. 
 For purification of CLA-DC, E. coli Rosetta/pCLA-DC cells (8 g) in 1.5 L of 
culture broth were suspended in standard buffer and disrupted with an Insonator 201M 
ultrasonic oscillator.  After centrifugation (20,000 × g, 30 min) of the cell lysate, solid sulfate 
was added to the resulting supernatant to 50–80% saturation.  The precipitate was recovered 
by centrifugation, dissolved in 10 ml standard buffer, and then dialyzed three times against 2 
L standard buffer for 8 h.  CLA-DC was purified further using a Phenyl Superose HR 10/10 
column and a Mono Q 5/50 GL column (GE Healthcare).  Purified CLA-DC was dialyzed 
with 50 mM KPB (pH 6.5) including 50% (v/v) glycerol and stored at −20°C until use. 
 
Reaction conditions 
Reactions were performed in test tubes (16.5 × 125 mm) that contained 1 mL of 
reaction mixture (20 mM KPB, pH 6.5) with 0.1% (w/v) fatty acid complexed with BSA 
(0.02% [w/v]) as the substrate, and purified enzymes (CLA-HY, CLA-DH, CLA-DC, and 
CLA-ER) in various combinations.  The reactions were performed with 5 mM NADH, 5 mM 
NAD+, 0.1 mM FMN, or 0.1 mM FAD under microaerobic conditions in a sealed chamber 
with an O2 absorber (Anaeropack “Kenki”, Mitsubishi Gas Chemical Co., Ltd., Tokyo, 
Japan), and gently shaken (120 strokes/min) at 37°C for 12 h.  The oxygen concentration 
under microaerobic conditions was maintained below 0.1% (<1000 ppm) and monitored with 
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an oxygen indicator (Mitsubishi Gas Chemical Co., Ltd.).  All experiments were performed 
in triplicate, and the averages of three separate experiments that were reproducible within 
±10% are presented in the figures.   
 
Lipid analyses 
Before lipid extraction, n-heptadecanoic acid was added to the reaction mixture as an 
internal standard.  Lipids were extracted from 1 mL of the reaction mixture with 5 mL of 
chloroform/methanol/1.5% KCl in H2O (2:2:1, by vol.), according to the procedure of Bligh-
Dyer, and concentrated by evaporation under reduced pressure (31).  The resulting lipids 
were dissolved in 2 mL of methanol and 3 mL of benzene, and then methylated with 300 µL 
of 1% trimethylsilyldiazomethane at 28°C for 30 min.  After methylation, the resulting fatty-
acid methyl esters were concentrated by evaporation under reduced pressure.  The resulting 
fatty-acid methyl esters were analyzed by gas-liquid chromatography (GC) using a Shimadzu 
(Kyoto, Japan) GC-1700 gas chromatograph equipped with a flame-ionization detector and 
split-injection system, fitted with a capillary column (SPB-1, 30 m × 0.25 mm I.D., Supelco, 
Bellefonte, PA, USA).  The initial column temperature was 180°C for 30 min, but was 
subsequently increased to 210°C at a rate of 60°C/min, and then maintained at that 
temperature for 29.5 min.  The injector and detector were operated at 250°C.  Helium was 
used as a carrier gas at a flow rate of 1.4 mL/min.  The fatty-acid peaks were identified by 
comparing retention times to known standards. 
 
Isolation and identification of reaction products 
Reaction products were separated by reverse-phase HPLC using a Shimadzu LC-10A 
system equipped with a Cosmosil column (5C18-AR, 20 × 250 mm, Nacalai Tesque, Kyoto, 
Japan).  The mobile phase was acetonitrile-H2O (8:2, by vol.) at a flow rate of 3.0 ml/min, 
and the effluent was monitored by ultraviolet detection (205 nm and 233 nm).  The methyl 
esters of purified fatty acids were transformed to the pyrrolidide and trimethylsilyl (TMS) 
derivatives.  Pyrrolidide derivatives were prepared by direct treatment of the purified fatty-
acid methyl esters with pyrrolidine-acetic acid (10:1, vol/vol) in screw-cap tubes for 1 h at 
115°C, followed by extraction with dichloromethane.  The organic extract was washed with 
water and dried over anhydrous Na2SO4, and then the solvent was removed under vacuum in 
a rotary evaporator.  The TMS derivatives were prepared by direct treatment of the purified 
fatty-acid methyl esters with a mixture of TMS agent 
(pyridine/hexamethyldisilazane/trimethylchlorosilane, 9:3:1, by vol.) in screw-cap tubes for 
30 min at 60°C followed by extraction with chloroform.  The chemical structures of purified 
fatty-acid methyl esters, pyrrolidide derivatives, and TMS derivatives were determined by 
mass spectroscopy (MS), and the chemical structures of purified free fatty acids were 
determined by two-dimensional proton nuclear magnetic resonance (1H-NMR) techniques 
including 1H-1H double–quantum-filtered chemical-shift correlation spectroscopy (DQF-
COSY), and two-dimensional nuclear Overhauser effect spectroscopy (NOESY), as 
described previously (20).   
 
Mice  
SPF and germ-free BALB/c mice (9 weeks, female) were obtained from CLEA Japan 
(Tokyo, Japan) and maintained under SPF and germ-free conditions with a sterile diet (CL-2, 
CLEA Japan), respectively, at the Experimental Animal Facility, Institute of Medical Science, 
The University of Tokyo.  Isolated tissues were immediately frozen by liquid nitrogen and 
always kept at −80°C prior to fatty-acid analysis.  All experiments were approved by the 
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Animal Care and Use Committee of The University of Tokyo and conducted in accordance 
with their guidelines. 
 
Fatty-acid analysis in mice 
LC-MS/MS-based lipidomics was performed as described (30).  Briefly, samples were 
subjected to solid-phase extraction using a Sep-Pak C18 cartridge (Waters) with a deuterium-
labeled internal standard (AA-d8, LTB4-d4, 15-HETE-d8, PGE2-d4).  Lipidomic analyses 
were performed using an HPLC system (Waters UPLC) with a linear ion-trap quadrupole 
mass spectrometer (QTRAP 5500; AB SCIEX) equipped with an Acquity UPLC BEH C18 
column (1.0 mm × 150 mm × 1.7 µm; Waters).  Samples were eluted with a mobile phase 
consisting of of water/acetate (100:0.1, vol/vol) and acetonitrile/methanol (4:1, vol/vol) 
(73:27) for 5 min; ramped to 30:70 after 15 min; ramped to 20:80 after 25 min, and held for 8 
min; and then ramped to 0:100 after 35 min, and held for 10 min with flow rates of 70 
µL/min (0–30 min), 80 µL/min (30-33 min), and 100 µL/min (33-45 min).  MS/MS analyses 
were conducted in negative-ion mode, and fatty-acid metabolites were identified and 
quantified by multiple-reaction monitoring (MRM).  Quantitation was perfomed using 
calibration curves constructed for each compound, and recoveries were monitored using 
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Figure 1  Gene clusters for polyunsaturated fatty-acid metabolism and GC 
chromatograms. 
A) Gene clusters for fatty-acid metabolic enzymes in L. plantarum.  B) GC chromatograms of 
1) substrate; 2) reaction with CLA-HY; 3) reaction with CLA-HY, CLA-DH, and CLA-DC 
together with FAD and NADH; and 4) reaction with CLA-HY, CLA-DH, CLA-DC, and 
CLA-ER together with FAD and NADH.  I.S., internal standard. 
 
Figure 2  Polyunsaturated fatty-acid metabolism pathway. 
 
Figure 3  Detection and quantitative analyses of polyunsaturated fatty acid saturation 
meatabolism intermediates in mice. 
Lipids extracted from colon (100 mg), intestine (100 mg), or plasma (100 µL) of specific 
pathogen–free (SPF) or germ-free (GF) mice were analyzed by LC-MS/MS-based lipidomics 
as described in Methods.  Data are presented as means ± SEM (n = 8).  The statistical 








































































Structural analysis of trans-10,cis-12-CLA 
The structure of trans-10,cis-12-CLA was confirmed by GC-MS and NMR 
analyses.  Mass spectra of pyrrolidide derivatives of the isolated fatty-acid methyl ester 
showed the same mass fragments pattern of pyrrolidide derivatives as commercially 
available trans-10,cis-12-CLA methyl ester (Figure S9).  Furthermore, 1H-NMR and 
DQF-COSY also suggested one partial structure as -CH2-CH=CH-CH=CH-CH2- 
(Figure S9).  Coupling constants between H-10 and H-11 and between H-12 and H-13 
were J = ~15 Hz and J = ~11 Hz, respectively, indicated that the Δ10 double bond was 
in the trans configuration and the Δ12 double bond was in the cis configuration [1H 
NMR dH (CDCl3): 6.29 (1H, dd, J = 11.6, 15.7 Hz, -CH=CH-CH=, H-11), 5.94 (1H, dd, 
J = 11.0, 11.0 Hz, =CH-CH=CH-, H-12), 5.65 (1H, dt, J= 15.1, 7.3 Hz, -CH2-CH=CH-, 
H-10), 5.30 (1H, dt, J = 10.8, 7.6 Hz, -CH=CH-CH2-, H-13), 3.67 (3H, s, -OCH3), 2.30 
(2H, t, J = 7.6 Hz, -C(=O)-CH2-CH2-, H-2), 2.15 (2H, dt, J = 6.3, 7.2 Hz, 
=CH-CH2-CH2-, H-14), 2.10 (2H, dt, J = 7.1, 6.5 Hz, -CH2-CH2-CH=, H-9), 1.26-1.63 
(18H, m, -CH2-CH2-CH2-, H-3, H-4, H-5, H-6, H-7, H-8, H-15, H-16, and 
-CH2-CH2-CH3, H-17), 0.89 (3H, t, J = 7.0, -CH2-CH3, H-18)]. 
Based on the results of these spectral analyses, the isolated fatty acid was 
identified as trans-10,cis-12-octadecadienoic acid (trans-10,cis-12-CLA) (Figure S9). 
 
Structural analysis of 10-oxo-cis-12-octadecenoic acid 
The structure of 10-oxo-cis-12-octadecenoic acid was confirmed by GC-MS and 
NMR analyses.  Mass spectra of the isolated fatty-acid methyl ester identified the 
isolated fatty acid as 10-oxo-12-octadecenoic acid.  1H-NMR and DQF-COSY also 
suggested one partial structure as -CH2-C(=O)-CH2-CH=CH-CH2- (Figure S10).  The 
coupling constant between H-12 and H-13 was J = 10.8 Hz, indicated that the Δ12 
double bond was in the cis configuration [1H NMR dH (CDCl3): 5.59 (1H, dt, J = 10.8, 
7.1 Hz, -CH=CH-CH2-, H-13), 5.53 (1H, dt, J = 10.8, 7.0 Hz, -CH2-CH=CH-, H-12), 
3.15 (2H, d, J = 6.8 Hz, -C(=O)-CH2-CH=, H-11), 2.43 (2H, t, J = 7.5 Hz, 
-CH2-CH2-C(=O)-, H-9), 2.35 (2H, t, J= 7.5 Hz, HOOC-CH2-CH2-, H-2), 2.03 (2H, dt, 
J = 7.3, 7.1 Hz, =CH-CH2-CH2-, H-14), 1.63 (2H, tt, J = 7.4, 7.4 Hz, -CH2-CH2-CH2-, 
H-3), 1.56 (2H, tt, J = 7.3, 7.3 Hz, -CH2-CH2-CH2-, H-8), 1.24–1.39 (14H, m, 
-CH2-CH2-CH2-, H-4, H-5, H-6, H-7, H-15, H-16, and -CH2-CH2-CH3, H-17), 0.89 (3H, 
t, J = 7.0 Hz, -CH2-CH3, H-18)]. 
Based on the results of these spectral analyses, the isolated fatty acid was 
identified as 10-oxo-cis-12-octadecenoic acid (Figure S10). 
 
Structural analysis of 10-oxo-trans-11-octadecenoic acid 
The structure of 10-oxo-trans-11-octadecenoic acid was confirmed by GC-MS 
and NMR analyses.  Mass spectra of the isolated fatty-acid methyl ester identified the 
isolated fatty acid as 10-oxo-11-octadecenoic acid.  1H-NMR and DQF-COSY also 
suggested one partial structure as -CH2-C(=O)-CH=CH-CH2- (Figure S11).  The 
coupling constant between H-11 and H-12 was J = 15.9 Hz, indicated that the Δ11 
double bond was in the trans configuration [1H NMR dH (CDCl3): 6.83 (1H, dt, J = 15.9, 
6.9 Hz, -CH=CH-CH2-, H-12), 6.09 (1H, d, J = 15.9 Hz, -C(=O)-CH=CH-, H-11), 2.52 
(2H, t, J = 7.5 Hz, -CH2-CH2-C(=O)-, H-9), 2.34 (2H, t, J = 7.5 Hz, HOOC-CH2-CH2-, 
H-2), 2.21 (2H, dt, J = 6.8, 6.8 Hz, =CH-CH2-CH2-, H-13), 1.61 (4H, m, 
-CH2-CH2-CH2-, H-3, H-8), 1.46 (2H, tt, J = 7.4 Hz, -CH2-CH2-CH2-, H-14), 1.23–1.38 
(14H, m, -CH2-CH2-CH2-, H-4, H-5, H-6, H-7, H-15, H-16, and -CH2-CH2-CH3, H-17), 
0.89 (3H, t, J = 6.9 Hz, -CH2-CH3, H-18)]. 
Based on the results of these spectral analyses, the isolated fatty acid was 
identified as 10-oxo-trans-11-octadecenoic acid (Figure S11). 
 
Structural analysis of 10-hydroxy-trans-11-octadecenoic acid 
The structure of 10-hydroxy-trans-11-octadecenoic acid was confirmed by 
GC-MS and NMR analyses.  Mass spectra of TMS derivatives of the isolated 
fatty-acid methyl ester identified the isolated fatty acid as 10-hydroxy-11-octadecenoic 
acid.  1H-NMR and DQF-COSY also suggested one partial structure as 
-CH2-CH(OH)-CH=CH-CH2- (Figure S12).  The coupling constant between H-11 and 
H-12 was J = 15.4 Hz, indicated that the Δ11 double bond was in the trans 
configuration [1H NMR dH (CDCl3): NMR dH (CDCl3): 5.63 (1H, dt, J = 15.4, 6.7 Hz, 
-CH=CH-CH2-, H-12), 5.44 (1H, dd, J = 7.2, 15.4 Hz, -CH(OH)-CH=CH-, H-11), 4.12 
(1H, dt, J = 7.2, 7.1 Hz, -CH2-CH(OH)-CH=, H-10), 2.33 (2H, t, J = 7.5 Hz, 
HOOC-CH2-CH2-, H-2), 2.02 (2H, dt, J = 7.0, 7.2 Hz, =CH-CH2-CH2-, H-13), 1.63 (2H, 
tt, J = 7.5, 7.3 Hz, -CH2-CH2-CH2-, H-3), 1.50 (2H, m, -CH2-CH2-CH(OH)-, H-9), 
1.22–1.39 (18H, m, -CH2-CH2-CH2-, H-4, H-5, H-6, H-7, H-8, H-14, H-15, H-16, and 
-CH2-CH2-CH3, H-17), 0.87 (3H, t, J = 13.9 Hz, -CH2-CH3, H-18)]. 
Based on the results of these spectral analyses, the isolated fatty acid was 
identified as 10-hydroxy-trans-11-octadecenoic acid (Figure S12). 
 
Structural analysis of 10-oxo-octadecanoic acid 
The structure of 10-oxo-octadecanoic acid was confirmed by GC-MS analysis.  
Mass spectra of the isolated fatty-acid methyl ester identified the isolated fatty acid as 
10-oxo-octadecanoic acid (Figure S13).  
 
Structural analysis of 10-hydroxy-octadecanoic acid 
The structure of 10-hydroxy-octadecanoic acid was confirmed by GC-MS 
analysis.  Mass spectra of TMS derivatives of the isolated fatty-acid methyl ester 
identified the isolated fatty acid as 10-hydroxy-octadecanoic acid (Figure S14).  
 
Structural analysis of oleic acid and trans-10-octadecenoic acid 
For isolation of octadecanoic acids, extracted fatty acids were separated by 
thin-layer chromatography (TLC) using TLC Glass Plates (Silica Gel 60, Merck), using 
a solvent system of hexane/diethyl ether/acetic acid (60/40/1, by vol.).  Fatty acids 
were detected under ultraviolet light (366 nm) after being sprayed with 0.01% primulin 
in 80% acetone.  The extracted free fatty acids were methylated, and the resultant 
fatty-acid methyl esters were purified with a Shimadzu LC-VP system fitted with a 
Silver column Kanto (4.6 × 250 mm, Kanto Chemical Co., Inc., Tokyo, Japan).  The 
mobile phase was hexane-acetonitrile (99.9:0.1, by vol.) at a flow rate of 1.0 ml/min, 
and the effluent was monitored by ultraviolet detection (200 nm and 206 nm).  Normal 
fatty acids were divided into trans-fatty acids, whose retention time was ~12 min, and 
cis-fatty acids, whose retention time was ~29 min.  The methyl esters of purified fatty 
acids were transformed to pyrrolidide derivatives as described previously20.  The 
structure of trans-10-octadecenoic acid was confirmed by GC-MS analysis.  Mass 
spectra of pyrrolidide derivatives of the purified trans–fatty-acid methyl ester identified 
the purified trans–fatty acid as trans-10-octadecenoic acid (Figure S15).  The structure 
of cis-9-octadecenoic acid was confirmed by GC-MS analysis.  Mass spectra of 
pyrrolidide derivatives of the purified cis–fatty-acid methyl ester showed the same mass 
fragments pattern of pyrrolidide derivatives as commercially available 
cis-9-octadecenoic acid methyl ester.  Based on the results of these analyses, the 
purified fatty acids were identified as trans-10- and cis-9-octadecenoic acids. 
 
  
Figure S1  Pathway for conversion of 10-hydroxy-cis-12-octadecenoic acid by 
CLA-HY, and GC chromatograms of a) before and b) after the reaction.  
 
Figure S2  Pathway for conversion of 10-hydroxy-cis-12-octadecenoic acid by 
CLA-DH, and GC chromatograms of a) before and b) after the reaction.  
 
 
Figure S3  Pathway for conversion of 10-oxo-cis-12-octadecenoic acid by 
CLA-DC, and GC chromatograms of a) before and b) after the reaction.  
 Figure S4  Pathway for conversion of 10-oxo-trans-11-octadecenoic acid by 
CLA-ER, and GC chromatograms of a) before and b) after the reaction.  
 
 
Figure S5  Pathway for conversion of 10-oxo-trans-11-octadecenoic acid by 
CLA-DH, and GC chromatograms of a) before and b) after the reaction.  
 Figure S6  Pathway for conversion of 10-oxooctadecanoic acid by CLA-DH, and 
GC chromatograms of a) before and b) after the reaction.  
 
Figure S7  Pathway for conversion of 10-hydroxyoctadecanoic acid by CLA-HY, 




Figure S8  Pathway for conversion of 10-hydroxy-trans-11-octadecenoic acid by 
CLA-HY, and GC chromatograms of a) before and b) after the reaction.  
 
 Figure S9  Structural identification of trans-10,cis-12-octadecadienoic acid.  
a) The structure of trans-10,cis-12-octadecadienoic acid. b) GC-MS analysis of 
pyrrolidide derivative of commercially available trans-10,cis-12-octadecadienoic acid 
methyl ester. c) GC-MS analysis of pyrrolidide derivative of isolated 
trans-10,cis-12-octadecadienoic acid methyl ester. d) DQF-COSY of isolated 
trans-10,cis-12-octadecadienoic acid. 
 
Figure S10  Structural identification of 10-oxo-cis-12-octadecenoic acid.  
a) The structure of 10-oxo-cis-12-octadecenoic acid. b) GC-MS analysis of 
10-oxo-cis-12-octadecenoic acid methyl ester. c) DQF-COSY of 
10-oxo-cis-12-octadecenoic acid.  
 
Figure S11  Structural identification of 10-oxo-trans-11-octadecenoic acid.  
a) The structure of 10-oxo-trans-11-octadecenoic acid. b) GC-MS analysis of 
10-oxo-trans-11-octadecenoic acid methyl ester. c) DQF-COSY of 
10-oxo-trans-11-octadecenoic acid.  
 
Figure S12  Structural identification of 10-hydroxy-trans-11-octadecenoic acid.  
a) The structure of 10-hydroxy-trans-11-octadecenoic acid. b) GC-MS analysis of TMS 
derivative of 10-hydroxy-trans-11-octadecenoic acid methyl ester. c) DQF-COSY of 
10-hydroxy-trans-11-octadecenoic acid.  
 Figure S13  Structural identification of 10-oxooctadecanoic acid.  
a) The structure of 10-oxooctadecanoic acid. b) GC-MS analysis of 10-oxooctadecanoic 
acid methyl ester.  
  
 
Figure S14  Structural identification of 10-hydroxyoctadecanoic acid.  
a) The structure of 10-hydroxyoctadecanoic acid. b) GC-MS analysis of TMS derivative 
of 10-hydroxyoctadecanoic acid methyl ester.  
  
 
Figure S15  Structural identification of trans-10-octadecenoic acid.  
a) The structure of trans-10-octadecenoic acid. b) GC-MS analysis of pyrrolidide 
derivative of trans-10-octadecenoic acid methyl ester.  
